Cancer Biomarkers : Section A of Disease Markers This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis
CONCLUSION: Overexpression of AURKA, CCNB1, CCNA2 and EXO1 had a better prognosis for CRC and this effect was correlation with gene mutation and infiltration of immune cells.PMID:38393891 | DOI:10.3233/CBM-230113 (Source: Cancer Biomarkers : Section A of Disease Markers)
Source: Cancer Biomarkers : Section A of Disease Markers - February 23, 2024 Category: Cancer & Oncology Authors: Shan Li Ting Li Yan-Qing Shi Bin-Jie Xu Yu-Yong Deng Xu-Guang Sun Source Type: research

The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma
CONCLUSIONS: Our results indicated that ferroptosis-related genes might play an important role in LIHC and STAD and might be risk factors for overall survival in LIHC and STAD.PMID:38393890 | DOI:10.3233/CBM-230114 (Source: Cancer Biomarkers : Section A of Disease Markers)
Source: Cancer Biomarkers : Section A of Disease Markers - February 23, 2024 Category: Cancer & Oncology Authors: Wenceng Pei Minren Jiang Haiyan Liu Jiahong Song Jian Hu Source Type: research

A risk model based on lncRNA-miRNA-mRNA gene signature for predicting prognosis of patients with bladder cancer
CONCLUSIONS: The risk model based on 13 DERs patterns could well predict the prognosis for patients with BC.PMID:38306023 | DOI:10.3233/CBM-230216 (Source: Cancer Biomarkers : Section A of Disease Markers)
Source: Cancer Biomarkers : Section A of Disease Markers - February 2, 2024 Category: Cancer & Oncology Authors: Zhi Yi Zhao Yin Cao Hong Liang Wang Ling Yun Liu Source Type: research

PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway
CONCLUSION: Our study confirms that PD-1 inhibitors in combination with Docetaxel are a viable combination strategy and provide a safe and effective combination option for the clinical treatment of prostate cancer.PMID:38306024 | DOI:10.3233/CBM-230090 (Source: Cancer Biomarkers : Section A of Disease Markers)
Source: Cancer Biomarkers : Section A of Disease Markers - February 2, 2024 Category: Cancer & Oncology Authors: Sixu Zhou Baogui Wang Yingying Wei Peiru Dai Yan Chen Yingyi Xiao Hongmei Xia Chunlin Chen Weihua Yin Source Type: research

Bioinformatics analysis of markers based on m6A related to prognosis combined with immune invasion of rectal adenocarcinoma
CONCLUSION: The model has been validated as a potential prognostic biomarker for rectal cancer in multiple dimensions, aiming to provide clinicians with an indicator to assess the duration of straight adenocarcinoma. This enables early detection of rectal cancer and offers a promising target for immunotherapy.PMID:38306025 | DOI:10.3233/CBM-230123 (Source: Cancer Biomarkers : Section A of Disease Markers)
Source: Cancer Biomarkers : Section A of Disease Markers - February 2, 2024 Category: Cancer & Oncology Authors: Shunkang Yan Jiandong Zhang Lianghe Li Gang Chen Zhongsheng Chen Wei Zhan Source Type: research